top of page
NeuroGenesis
Cell therapies for neurodegenerative diseases
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
NeuroGenesis | 02/09/2022 | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | Biochemical: pharmacological drugs (Developing drugs) | 01/01/2019 |
NeuroGenesis is a clinical-stage biotechnology company.
We are advancing innovative cell therapies via our propriety NEURALyzed CELL™ platform to combat neurodegenerative diseases
bottom of page